MetLife Files 8-K with Financial Statements
Ticker: MET-PF · Form: 8-K · Filed: Mar 5, 2024 · CIK: 1099219
| Field | Detail |
|---|---|
| Company | Metlife Inc (MET-PF) |
| Form Type | 8-K |
| Filed Date | Mar 5, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 M, $0.42000544, $25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-statements, exhibits, disclosure
Related Tickers: MET
TL;DR
MetLife filed its 8-K, mostly just paperwork and financial exhibits.
AI Summary
On March 5, 2024, MetLife, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific new events or material changes detailed in the provided text. It confirms MetLife's principal executive offices are located at 200 Park Avenue, New York, NY 10166-0188.
Why It Matters
This filing serves as a routine update for investors, confirming MetLife's financial reporting status and corporate information.
Risk Assessment
Risk Level: low — The filing is a standard disclosure and does not indicate any new risks or material adverse events.
Key Players & Entities
- METLIFE, INC. (company) — Registrant
- 200 Park Avenue, New York, NY 10166-0188 (location) — Principal Executive Offices
FAQ
What is the purpose of this 8-K filing for MetLife, Inc.?
The 8-K filing on March 5, 2024, is primarily for reporting financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.
What is MetLife, Inc.'s principal executive office address?
MetLife, Inc.'s principal executive offices are located at 200 Park Avenue, New York, NY 10166-0188.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is March 5, 2024.
Under which section of the Securities Exchange Act is this report filed?
This is a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is MetLife, Inc.'s state of incorporation?
MetLife, Inc. is incorporated in Delaware.
Filing Stats: 544 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-03-05 16:22:50
Key Financial Figures
- $0.01 M — ich registered Common Stock, par value $0.01 MET New York Stock Exchange Floating Rat
- $0.42000544 — ion of a first quarter 2024 dividend of $0.42000544 per share on MetLife, Inc.'s floating r
- $25 — n-cumulative preferred stock, Series A, $25 liquidation preference per share. A cop
Filing Documents
- met-20240305.htm (8-K) — 30KB
- ex991newsrelease030524.htm (EX-99.1) — 8KB
- metlogo20202a02.jpg (GRAPHIC) — 25KB
- 0001099219-24-000067.txt ( ) — 251KB
- met-20240305.xsd (EX-101.SCH) — 2KB
- met-20240305_def.xml (EX-101.DEF) — 16KB
- met-20240305_lab.xml (EX-101.LAB) — 32KB
- met-20240305_pre.xml (EX-101.PRE) — 17KB
- met-20240305_htm.xml (XML) — 6KB
01 Other Events
Item 8.01 Other Events. On March 5, 2024, MetLife, Inc. issued a news release confirming its previously announced declaration of a first quarter 2024 dividend of $0.42000544 per share on MetLife, Inc.'s floating rate non-cumulative preferred stock, Series A, $25 liquidation preference per share. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. 99.1 MetLife, Inc. news release dated March 5, 2024, confirming its previously announced declaration of a first quarter 2024 dividend on its floating rate non-cumulative preferred stock, Series A. 101 Pursuant to Rule 406 of Regulation S-T, the cover page is formatted in Inline XBRL (Inline eXtensible Business Reporting Language) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. METLIFE, INC. By: /s/ Timothy J. Ring Name: Timothy J. Ring Title: Senior Vice President and Secretary Date: March 5, 2024